Regulus Therapeutics Inc. Financial Ratios — RGLS Stock

Profitability (USD)

	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-35.46	-23.78	-16.48	-38.49	-35.67	-67.7	-80.58	-92.13	-53.11	-39.48	-52.44	-49.18	-77.55	-80.67
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	100	100	100	100	100	100	100	100	100	100	100	- -	- -	- -	- -
EBITDA Margin (%)	-174.44	-45.15	-91	-84.02	-566.18	-256.12	-6,635.34	-93,898.61	-61,806.94	-232.77	-136.8	- -	- -	- -	- -
Operating Margin (%)	-180.19	-51.76	-99.01	-90.97	-585.6	-263.78	-6,825.96	-97,404.17	-64,948.61	-246.4	-141.47	- -	- -	- -	- -
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	136.53	- -	- -	- -
Pretax Margin (%)	-181.25	-53.64	-137.15	-95.51	-739.07	-268.64	-6,854.27	-100,141.67	-67,565.28	-272.12	-157.21	- -	- -	- -	- -
Profit Margin (%)	-180.9	-55.13	-137.07	-95.4	-739.08	-268.55	-6,853.94	-99,868.06	-67,651.39	-272.13	-157.21	- -	- -	- -	- -
Net Income to Common Margin (%)	-180.9	-55.13	-137.07	-95.4	-739.08	-268.55	-6,853.94	-99,868.06	-67,651.39	-272.13	-157.21	- -	- -	- -	- -
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
Total Debt	- -	10	10	11	23	- -	20	20	17	15	5	7	6	2	- -
ST Debt	- -	- -	- -	- -	23	- -	- -	20	17	15	5	- -	5	1	- -
LT Debt	- -	10	10	11	- -	- -	20	- -	- -	- -	- -	7	2	1	- -
Total Debt/EBITDA	- -	-1.67	-0.88	-0.69	-0.54	- -	-0.25	-0.29	-0.37	-0.92	-0.34	-0.26	-0.22	-0.08	-0.01
Net Debt/EBITDA	- -	-0.13	2.63	0.4	0.32	0.3	-0.06	-0.09	-0.06	1.23	1.93	2.04	0.7	0.73	0.78
Total Debt/EBIT	- -	-1.45	-0.81	-0.63	-0.52	- -	-0.24	-0.28	-0.35	-0.87	-0.33	-0.25	-0.22	-0.08	-0.01
Net Debt/EBIT	- -	-0.12	2.42	0.37	0.31	0.29	-0.06	-0.09	-0.06	1.16	1.87	2	0.7	0.72	0.77
EBITDA to Interest Expense	-41.45	-16.05	-46.79	-456.72	-1,113.33	-1,022.44	-67.03	-24.83	-18.99	-7.46	-7.57	-32	-40.87	-51.13	-314.51
EBITDA-CapEx/Interest Expense	-48.12	-17.59	-52.56	-479.92	-1,144.38	-1,049.94	-67.84	-24.95	-19	-7.58	-7.58	-32.29	-41.39	-52.14	-316.66
EBIT to Interest Expense	-42.81	-18.39	-50.91	-494.5	-1,151.54	-1,053.04	-68.95	-25.76	-19.96	-7.9	-7.83	-32.53	-41.05	-51.5	-316.71
Interest Expense	- -	- -	- -	- -	- -	- -	1	3	2	2	2	1	1	1	- -
Common Equity/Total Assets	- -	-100.3	-58.33	-64.23	-79.15	-135.71	-271.5	-444.48	-1,406.22	-977.39	-1,135.46	-664.44	-1,034.25	-1,668.92	-664.65
Long-Term Debt/Equity (%)	- -	- -	16.32	12.07	- -	- -	35.31	- -	- -	- -	- -	12.9	5.31	4.98	0.36
Long-Term Debt/Capital (%)	- -	99.43	-20.17	-16.64	- -	- -	-7.81	- -	- -	- -	- -	-1.58	-0.37	-0.21	-0.05
Long-Term Debt/Total Assets (%)	- -	23.32	9.79	9.17	- -	- -	19.67	- -	- -	- -	- -	10.36	3.78	3.43	0.33
Total Debt/Equity (%)	- -	-25.01	16.32	12.07	17.72	- -	35.31	56.39	-283.14	73.1	17.87	12.9	18.86	11.28	0.36
Total Debt/Capital (%)	- -	103.18	-20.17	-16.64	-20.83	- -	-7.81	-6.09	-4.41	-3.69	-1.1	-1.58	-1.32	-0.47	-0.05
Total Debt/Total Assets (%)	- -	24.2	9.79	9.17	13.64	- -	19.67	25.52	59.35	34.77	12.37	10.36	13.44	7.77	0.33
Net Debt to Equity	- -	-1.99	-48.99	-6.99	-10.55	-12.86	8.67	18	-45.1	-97.38	-101.57	-101.37	-59.23	-105.88	-50.42
Net Debt/Capital (%)	- -	93.54	33.5	7.63	9.31	7.69	-1.81	-1.87	-0.68	4.52	5.83	10.96	3.93	4.2	6.45
EBITDA	-15	-6	-12	-16	-43	-53	-79	-68	-45	-16	-14	-27	-28	-31	-50
EBITDA-CapEx	-17	-7	-13	-17	-45	-55	-80	-68	-45	-16	-14	-28	-28	-31	-50
Operating Income (Loss)	-15	-7	-13	-18	-45	-55	-82	-70	-47	-17	-14	-28	-28	-31	-50

Liquidity (USD)

API Chat

	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
Cash Ratio	- -	2.97	7.68	10.99	4.54	9.03	5.51	1.84	0.52	1.58	2.69	11.55	3.36	2.79	10.1
Current Ratio	- -	3.01	7.75	11.3	4.69	10.63	6.34	2.05	0.72	1.87	3.17	12.48	3.78	3.31	10.98
Quick Ratio	- -	2.97	7.68	11	4.55	9.82	5.63	1.85	0.52	1.63	2.73	11.55	3.36	2.79	10.1
CFO/Avg Current Liab	- -	-2.34	-0.68	-2.45	-1.73	-2.09	-4.3	-2.53	-1.46	-0.82	-0.76	-2.87	-3.02	-2.65	-5.21
Common Equity/Total Assets	- -	-100.3	-58.33	-64.23	-79.15	-135.71	-271.5	-444.48	-1,406.22	-977.39	-1,135.46	-664.44	-1,034.25	-1,668.92	-664.65
Long-Term Debt/Equity (%)	- -	- -	16.32	12.07	- -	- -	35.31	- -	- -	- -	- -	12.9	5.31	4.98	0.36
Long-Term Debt/Capital (%)	- -	99.43	-20.17	-16.64	- -	- -	-7.81	- -	- -	- -	- -	-1.58	-0.37	-0.21	-0.05
Long-Term Debt/Total Assets (%)	- -	23.32	9.79	9.17	- -	- -	19.67	- -	- -	- -	- -	10.36	3.78	3.43	0.33
Total Debt/Equity (%)	- -	-25.01	16.32	12.07	17.72	- -	35.31	56.39	-283.14	73.1	17.87	12.9	18.86	11.28	0.36
Total Debt/Capital (%)	- -	103.18	-20.17	-16.64	-20.83	- -	-7.81	-6.09	-4.41	-3.69	-1.1	-1.58	-1.32	-0.47	-0.05
Total Debt/Total Assets (%)	- -	24.2	9.79	9.17	13.64	- -	19.67	25.52	59.35	34.77	12.37	10.36	13.44	7.77	0.33
CFO/Total Liabilities	- -	-17.85	-21.05	-95.68	-100.11	-293.2	-127.58	-137.99	-128.1	-89.83	-108.27	-178.78	-190.14	-279.91	-536.13
CFO/CapEx	5.1	-25.19	-6.12	-33.93	-32.63	-34.87	-58.88	-184.24	-1,966.95	-81.23	-1,139.64	-96.13	-70.71	-43.67	-122.57
Altman's Z-Score	- -	-0.93	0.65	5.58	9.72	13.8	-4.04	-7.66	-25.85	-13.98	-13.68	-8.38	-14.73	-24.44	-3.33

Working Capital (USD)

API Chat

	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
Accounts Receivable Turnover	- -	- -	- -	495.42	43.45	151.53	- -	0.39	0.36	11.71	12.17	- -	- -	- -	- -
Days Sales Outstanding	- -	- -	- -	0.74	8.4	2.41	- -	945.45	1,011.35	31.17	29.99	- -	- -	- -	- -
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	2.26	- -	-0.13	-1.28	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	161.49	173,516.94	-2,748.89	-284.53	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	6	6	5	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	6	6	5	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
Market Capitalization	- -	- -	52	284	707	448	119	78	8	15	47	27	21	24	89
- Cash & Cash Equivalents	- -	9	41	18	37	16	15	14	14	34	31	60	24	24	39
+ Preferred Equity and Hybrid Capital	- -	43	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	10	10	11	23	- -	20	20	17	15	5	7	6	2	- -
Enterprise Value	- -	15	-36	182	571	334	63	38	11	-4	21	-26	-12	3	14
Total Capital	- -	10	-50	-68	-112	-191	-253	-326	-376	-397	-422	-448	-477	-511	-559
Total Debt/Capital (%)	- -	103.18	-20.17	-16.64	-20.83	- -	-7.81	-6.09	-4.41	-3.69	-1.1	-1.58	-1.32	-0.47	-0.05
Total Debt / EV	- -	0.7	-0.28	0.06	0.04	- -	0.32	0.52	1.54	-3.55	0.22	-0.27	-0.52	0.82	0.02
EV/Sales	- -	1.08	- -	9.28	74.44	16.1	52.36	528.12	149.28	- -	2.08	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	52	284	707	448	119	78	8	15	47	27	21	24	89
Diluted Enterprise Value	- -	44	21	278	693	432	124	85	11	-4	21	-26	3	3	51
EV per Share	- -	6,977.09	- -	566.44	1,553.71	780.16	142.06	60.65	12.33	- -	5.94	- -	- -	0.15	0.24
TTM Sales	9	14	13	20	8	21	1	- -	- -	7	10	- -	- -	- -	- -
TTM EBITDA	-15	-6	-12	-16	-43	-53	-79	-68	-45	-16	-14	-27	-28	-31	-50
TTM Operating Income	-15	-7	-13	-18	-45	-55	-82	-70	-47	-17	-14	-28	-28	-31	-50
TTM Cash Flow to Firm	13	-15	-8	-28	-39	-50	-56	-56	-41	-18	-11	-23	-25	-26	-42
TTM Free Cash Flow to Firm	15	-14	-7	-27	-38	-48	-55	-56	-41	-17	-11	-23	-24	-26	-41

Multiples (USD)

API Chat

	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
Price/Free Cash Flow	- -	- -	-7.09	-10.34	-18.47	-9.26	-2.13	-1.34	-0.19	-0.78	-3.77	-1.15	-0.83	-0.93	-2.15
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	- -	15	-36	182	571	334	63	38	11	-4	21	-26	-12	3	14
Low Price	- -	- -	482.4	560.4	648	702	255.6	94.8	8	5	4.2	3.2	1.08	0.76	1.08
EV/Sales	- -	1.08	- -	9.28	74.44	16.1	52.36	528.12	149.28	- -	2.08	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	-2.24	-15.94	-7.45	-11.1	-3.01	-1.33	-1.18	-0.87	-1.62	-2.89	-1.13	-0.86	-2.17
Price/Earnings High	- -	- -	-3.06	-26.57	-19.91	-19.57	-5.74	-2.72	-3.09	-1.5	-3.87	-7.15	-1.99	-1.35	-4.61
Price/Earnings Low	- -	- -	-1.9	-9.63	-4.2	-5.39	-1.37	-0.83	-0.14	-0.46	-0.93	-0.99	-0.58	-0.48	-1.31
Price/Book Value	- -	- -	-0.86	-3.6	-5.21	-2.34	-0.43	-0.23	-0.02	-0.04	-0.11	-0.06	-0.04	-0.05	-0.16
Price/Book Value Average	- -	- -	-0.65	-3.76	-3.11	-3.23	-0.9	-0.28	-0.15	-0.04	-0.06	-0.18	-0.07	-0.05	-0.18
Price/Book Value High	- -	- -	-0.88	-6.27	-8.32	-5.7	-1.72	-0.57	-0.38	-0.07	-0.14	-0.44	-0.12	-0.08	-0.38
Price/Book Value Low	- -	- -	-0.55	-2.27	-1.75	-1.57	-0.41	-0.17	-0.02	-0.02	-0.03	-0.06	-0.03	-0.03	-0.11
Price/Tangible Book Value	- -	- -	0.85	3.08	5.4	3.64	2.16	2.27	-1.28	0.78	1.82	0.5	0.63	1.15	1.17
Price/Tangible Book Value Average	- -	- -	0.64	3.22	3.23	5.03	4.48	2.77	-9.07	0.82	0.98	1.46	0.96	1.22	1.32
Price/Tangible Book Value High	- -	- -	0.87	5.37	8.62	8.87	8.54	5.68	-23.71	1.42	2.35	3.62	1.7	1.92	2.8
Price/Tangible Book Value Low	- -	- -	0.54	1.95	1.82	2.45	2.04	1.73	-1.1	0.44	0.57	0.5	0.5	0.68	0.8
Price/Sales	- -	- -	4.07	14.53	92.22	21.6	99.52	1,086.66	112.61	2.25	4.72	- -	- -	- -	- -
Price/Sales Average	- -	- -	3.07	15.2	55.05	29.82	206.48	1,325.69	800.16	2.36	2.55	- -	- -	- -	- -
Price/Sales High	- -	- -	4.2	25.35	147.18	52.55	393.67	2,716.65	2,092.45	4.09	6.08	- -	- -	- -	- -
Price/Sales Low	- -	- -	2.6	9.18	31.05	14.49	94.21	825.44	96.87	1.26	1.47	- -	- -	- -	- -
Price/Cash Flow	- -	- -	-5.93	-10.04	-17.9	-8.99	-2.09	-1.33	-0.19	-0.78	-3.77	-1.14	-0.82	-0.91	-2.14
Price/Cash Flow Average	- -	- -	-4.48	-10.5	-10.69	-12.41	-4.33	-1.62	-1.33	-0.81	-2.03	-3.33	-1.25	-0.96	-2.41
Price/Cash Flow High	- -	- -	-6.11	-17.51	-28.57	-21.88	-8.26	-3.33	-3.48	-1.41	-4.85	-8.24	-2.21	-1.52	-5.12
Price/Cash Flow Low	- -	- -	-3.79	-6.34	-6.03	-6.03	-1.98	-1.01	-0.16	-0.44	-1.17	-1.14	-0.65	-0.54	-1.46
Price/Free Cash Flow Average	- -	- -	-5.35	-10.82	-11.02	-12.78	-4.41	-1.63	-1.33	-0.82	-2.04	-3.36	-1.27	-0.99	-2.43
Price/Free Cash Flow High	- -	- -	-7.31	-18.04	-29.47	-22.53	-8.41	-3.35	-3.48	-1.43	-4.86	-8.33	-2.24	-1.55	-5.17
Price/Free Cash Flow Low	- -	- -	-4.53	-6.54	-6.22	-6.21	-2.01	-1.02	-0.16	-0.44	-1.17	-1.15	-0.65	-0.55	-1.47
EV/Sales Average	- -	3.18	0.68	14.87	53.23	29.05	210.55	1,413.75	836.82	- -	- -	- -	- -	- -	- -
EV/Sales High	- -	3.18	1.8	25.01	145.36	51.78	397.74	2,804.71	2,129.12	1.24	3.44	- -	- -	- -	- -
EV/Sales Low	- -	3.18	0.2	8.85	29.23	13.72	98.29	913.5	133.54	- -	- -	- -	- -	- -	- -
EV/EBITDA Average	- -	-7.05	-0.75	-17.7	-9.4	-11.34	-3.17	-1.51	-1.35	0.21	0.07	-0.99	-0.5	-0.14	-1.25
EV/EBITDA High	- -	-7.05	-1.98	-29.77	-25.67	-20.22	-5.99	-2.99	-3.44	-0.53	-2.52	-5.32	-1.37	-0.62	-3.53
EV/EBITDA Low	- -	-7.05	-0.22	-10.53	-5.16	-5.36	-1.48	-0.97	-0.22	0.68	0.86	0.95	0.05	0.23	-0.45
EV/EBIT Average	- -	-6.15	-0.69	-16.34	-9.09	-11.01	-3.08	-1.45	-1.29	0.2	0.07	-0.97	-0.5	-0.14	-1.25
EV/EBIT High	- -	-6.15	-1.82	-27.5	-24.82	-19.63	-5.83	-2.88	-3.28	-0.5	-2.43	-5.23	-1.36	-0.62	-3.5
EV/EBIT Low	- -	-6.15	-0.21	-9.73	-4.99	-5.2	-1.44	-0.94	-0.21	0.64	0.83	0.93	0.05	0.22	-0.45
Last Price	- -	- -	756	886.8	1,924.8	1,046.4	270	124.8	9.3	8.9	13.5	3.2	1.37	1.28	1.58
High Price	- -	- -	778.8	1,546.8	3,072	2,546.4	1,068	312	172.8	16.2	17.4	23.2	3.7	2.14	3.79
Enterprise Value Average	- -	44	9	291	408	603	251	102	60	-3	-1	27	14	4	62
Enterprise Value High	- -	44	23	489	1,115	1,075	475	202	153	8	34	146	39	19	175
Enterprise Value Low	- -	44	3	173	224	285	117	66	10	-11	-12	-26	-1	-7	23

	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
Shares Outstanding	- -	- -	- -	- -	- -	- -	- -	1	1	2	7	15	17	20	66
Diluted Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	1	1	2	3	9	15	19	56
Basic Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	1	1	2	3	9	15	19	56
Revenue per Share	4,021.04	6,446.47	185.57	61.03	20.87	48.45	2.71	0.11	0.08	3.96	2.86	- -	- -	- -	- -
EBITDA per Share	-7,014.49	-2,910.71	-168.87	-51.28	-118.18	-124.1	-180.01	-107.84	-51.04	-9.21	-3.91	-3.19	-1.84	-1.63	-0.88
Operating Income per Share	-7,245.44	-3,336.61	-183.73	-55.52	-122.23	-127.81	-185.19	-111.87	-53.64	-9.75	-4.05	-3.25	-1.85	-1.64	-0.89
Basic EPS, GAAP	-7,273.96	-3,554	-254.37	-58.22	-154.27	-130.12	-185.94	-114.7	-55.87	-10.77	-4.5	-3.24	-1.86	-1.58	-0.82
Basic EPS from Cont Ops	-7,273.96	-3,554	-254.37	-58.22	-154.27	-130.12	-185.94	-114.7	-55.87	-10.77	-4.5	-3.24	-1.86	-1.58	-0.82
Diluted EPS, GAAP	-7,273.96	-3,554	-254.37	-58.22	-154.27	-130.12	-185.94	-114.7	-55.87	-10.77	-4.5	-3.24	-1.86	-1.58	-0.82
Diluted EPS from Cont Ops	-7,273.96	-3,554	-254.37	-58.22	-154.27	-130.12	-185.94	-114.7	-55.87	-10.77	-4.5	-3.24	-1.86	-1.58	-0.82
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	5,753.62	-7,042.08	-127.43	-88.35	-107.53	-116.38	-129.24	-93.75	-49.63	-11.48	-3.58	-2.82	-1.67	-1.41	-0.74
Free Cash Flow per Basic Share	4,624.59	-7,321.65	-148.27	-90.95	-110.83	-119.71	-131.44	-94.26	-49.66	-11.63	-3.59	-2.84	-1.7	-1.44	-0.75
Cash & Equivalents per Share	- -	17,832.63	1,433.44	355.53	434.77	266.24	172.94	95.82	15.98	19.77	8.89	7.05	2.57	1.25	1.34
Book Value per Share	- -	-20,107.99	-882.32	-246.51	-369.39	-446.9	-620.98	-551.66	-450.43	-238.29	-122.07	-53.07	-31.66	-27.07	-9.93
Tangible Book Value per Share	- -	-39,815.33	890.44	287.93	356.17	287.09	125.11	54.94	-7.29	11.44	7.4	6.4	2.18	1.12	1.36

Regulus Therapeutics Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)